Intelligent Surgical Unit™ (ISU™)
Augmented Intelligence for Surgical Guidance
Approved/CommercialIntegrated Commercial Feature
Key Facts
Indication
Augmented Intelligence for Surgical Guidance
Phase
Approved/Commercial
Status
Integrated Commercial Feature
Company
About Asensus Surgical
Asensus Surgical is revolutionizing minimally invasive surgery by developing and commercializing the Senhance® Surgical System, a robotic platform integrated with the first globally approved intra-operative augmented intelligence system. The company focuses on reducing surgical variability, improving surgeon ergonomics, and increasing accessibility through reusable instruments and a lower-cost model. Following its acquisition by KARL STORZ, Asensus is positioned to accelerate the global adoption of its digital surgery technology, aiming to set a new standard of care in robotic-assisted procedures.
View full company profile